Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Evonik Catalysts expands Production of Activated Metal Catalysts in India - The Pharma Times | Pharma & Health Care News Portal
Categories: Business News

Evonik Catalysts expands Production of Activated Metal Catalysts in India

• New plant for Activated Metal Catalysts in India

• Latest technology greatly enhances supply with high-quality catalysts for the Asia Pacific region

• Significant synergies with production site in Germany makes Evonik one of the leading manufacturers for Activated Metal Catalysts

Mumbai April 10 ,2019:  At Evonik Catalyst’s manufacturing site in Dombivli, India, the company is commissioning a new plant initially for the production of KALCATTMand in the long-term also Metalyst® ActivatedMetal Catalysts. This new state of the art production facility allows Evonik to fully utilize its capacities in Dombivli while establishing significant synergies with the Activated Metal Catalyst production site in Germany.

Activated Metal Catalysts are used in the food industry for the production of sorbitol, the manufacture of active pharmaceutical ingredients (APIs) and in the production of fine and industrial chemicals, for example in the polyurethane value chain. The benefit to customers will be increased supply security of high-quality catalysts which are critical raw materials for most industrial processes. The growth rate for India and the rest of Asia in the catalyst market, is forecasted to be significantly higher than in other regions of the world. Therefore, this expansion and upgrade of operations will safeguard the supply of the established product range as well as allowing Evonik to expand the portfolio targeting new markets and applications.

“With this new production facility we will be able to increase our ability to supply our customers with technologically advanced products in India and abroad”, states Dr. Thomas Tacke, Managing Director Evonik Catalysts India.Dr. Steffen Hasenzahl, Head of Business Line Catalyst adds: “This expansion of operations in Dombivli is part of our long-term strategy to enhance the expertise and capabilities in the Asia Pacific region. Additionally, it is an important step forward in our commitment to support our valued partners in the region.” “It is one more step towards the company’s commitment to increase our footprint in the growth region” concluded, Mr. Sanjeev Taneja, President, and Managing Director, Evonik India.

Corporate Comm India(CCI NewsWire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

4 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

6 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago